PURPOSE: To provide physicians and promotes with an overview of mycotic infections and related cutaneous manifestations.

TARGET AUDIENCE: This continuing-education activity is intended for physicians and cherishs with an interest in learning by what mode to recognize and treat mycotic skin infections.

OBJECTIVES: After reading the article and taking the experiment the participant will be able to:

1 Identify the cause and clinical presentation of mycotic skin infections.

2 Identify diagnostic trials used in evaluating patients with mycotic skin infections.

3 Identify appropriate treatment options in patients with mycotic skin infections.

Mycotic diseases affect a substantial number of race worldwide and can cause significant morbidity and mortality.1'2 The number of cases has multiplied with the increase in world travel and immunosuppression.

Broadly speaking, mycotic infections can be classified as either superficial or hard Superficial mycotic infections, or dermatophytes, have affinity for keratin and, therefore, are typically limited to either the epidermis or adnexal forms Deep mycotic infections affect difficult structures. Cutaneous manifestations of intelligent mycotic infections occur from primary infection of the skin or from cutaneous dissemination owing to a systemic infection. This article focuses forward deep mycotic infections and related cutaneous manifestations.

SPOROTRICHOSIS

Sporotrichosis is caused by way of the dimorphic fungus Sporothrix schenckii, which can be isolated from decaying vegetation, soil, timbers, thorns, animal claws, and sphagnum moss34 (A dimorphic fungus can advance in different forms at different temperatures. For example, at chamber temperature, S schenckii grows in a mycelial form; at 37[degrees]C it put forths in a yeast form.) Sporotrichosis is usually ground in the United States if it were not that has also been reported in Central and toward the south America, Australia, Asia, and Africa. Florists, gardeners, veterinarians, farmers, and laboratory workers are at the greatest risk for acquiring Sporotrichosis.

Manifestation

Sporotrichosis can be categorized as lymphocutaneous, fixed cutaneous, or disseminated.3,4 Lymphocutaneous Sporotrichosis, the in the greatest degree common form of Sporotrichosis, is characterized by means of painless, hard, pink nodules in succession the distal extremities, which appear 3 weeks to 6 month after infection.

Once a lesion unravels others will develop near the infection site during the nearest several weeks. As the organism spreads via the lymphatic scheme lesions occur in a pattern following the lymphatic tract of the area (Figure 1) Papules and nodules that expand often undergo necrosis and subsequently ulcerate, revealing a ragged base. At this point, the sore s may develop thin crusts or verrucous changes or may continuously drain serous fluid. Significant scarring may ultimately occur

Fixed cutaneous Sporotrichosis existings as localized lesions involving the face, neck body and legs without lymphatic involvement.3,4 Lesions typically manifest as ulcerated nodules, verrurous plaques, scaly patches, and/or acneiform eruptions. Patients with a stronger immune body or those who have been infected with a inferior volume of S schenckii are more likely to make known this form of Sporotrichosis.

Disseminated Sporotrichosis befalls via hematogenous spread of the organism from a primary infection site or from a regional lymph node involved in primary infection.3,4 It can manifest within the kidneys, teste bone joints, lung and central nervous arrangement This form is rare and is usually associated with immunosuppression, in the same state [i]or[/i] condition as in patients with lymphoma, diabetes mellitus, or AIDS.5

Diagnosis

The gold standard for diagnosing sporotrichosis is fungal culture34 Sporotrichosis waxs best at 25[degrees]C; tissue, pus, aspirates, or swab agriculture material can be cultured in succession Sabouraud or Mycosel media. In agriculture S schenckii appears as a white, plain or verrucous colony with aerial mycelium, which subsequently diverts brown, then black. S schenckii is a dimorphic fungus, growing as yeast at 37[degrees]C and mycelium at stead temperatur. Microscopically, thin branching hyphae with pyriform conidia can be seen Special stains, consisting of paraaminosalicylic acid (FAS) or Gomori, can be used to visualize these cigar-shaped fungi in succession biopsy specimens. However, biopsies rarely lead to a clear diagnosis because scarcely any organisms are usually recovered onward examination.6 Direct fluorescent antibody testing of tissue yields a more rapid diagnosis. Serum agglutinins, precipitins, and complement-fixing antibodies can also be used to establish a diagnosis.

Treatment

Patients with the fixed cutaneous and lymphocutaneous forms of sporotrichosis can be treated with an oral potassium iodide solution, starting at 1 mL 3 times by day.3,4 The dosage should be increased by the agency of 1.5 m L per day until reaching a maximum of 18 mL by day. Although not cytotoxic, iodides work by way of increasing the patient's immune answer against the fungus. Treatment should continue for 4 weeks if no adverse adventures such as nausea or vomiting, appear If the patient cannot tolerate oral iodides, intravenous (IV) sodium iodide at 1 g daily can be used 7for 4 weeks.

...

Home